EPHA4 and neoplasm: In agreement with a dual role of EphA4 even in the same tumor type, our analysis of EphA4 melanoma mutations identified two mutations (G733W and R745C) that abrogate EphA4 kinase activity and the L920F mutation, which increases kinase activity.